2016 Doctors Leads 
World of DTC Marketing
MARCH 6, 2022
A 2016 study reported that 259,000 digital health apps were available for consumers. A record number (296) of private digital health companies received venture funding in 2016, funding that totaled more than $4.2 Maybe, however, they should check with patients first. billion that year and approached $6 billion the following year.
World of DTC Marketing
JUNE 1, 2021
Too many doctors, the data was still questionable. After aducanumab showed promise in 2016, Biogen launched two late-stage trials — then stopped them halfway through, in March 2019, when an analysis concluded the studies would not reach their goal of slowing cognitive and functional impairment in participants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 1, 2022
Between 2016 and 2019, DNDi and its partners led an open-label, Phase II/III study to assess the safety and efficacy of acoziborole in patients with early- and late-stage g-HAT. About the Phase II/III study. 208 patients were recruited at 10 hospitals in the Democratic Republic of the Congo (DRC) and Guinea.
InCrowd
AUGUST 4, 2022
I can not only be “The Latina” or “The woman” or “The young doctor”, I am all of them and with them comes the price I sadly am forced to pay. The Oxford handbook of feminist theory: Oxford University Press; 2016. Intersectionality is the sum of all my identities and all the negative association that come with them. Duran A, Jones SR.
Pharmaceutical Technology
MARCH 24, 2023
However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars.
pharmaphorum
AUGUST 11, 2022
In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 The best way to do that is to target specific sub-populations, which will serve as a natural lead into personalised medicine becoming more mainstream. billion in the United States alone.
Medico Reach
SEPTEMBER 12, 2022
In the absence of modern technology, doctors could only perform open surgeries involving major incisions on the patient’s body, usually resulting in a permanent scar. However, the advent of endoscopic devices meant that doctors could rapidly diagnose multiple issues without needing experimental surgeries.
Expert insights. Personalized for you.
244 
Let's personalize your content